Procept Biorobotics Corp (PRCT NASDAQ) stock market data APIs
$56.9531
1.31(2.3%)
as of July 11, 2025
Try our APIs with
free plan!
Procept Biorobotics Corp Financial Data Overview
Price chart is built with
Anychart
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Prev. Close
56.9531
Open
58.2666
High
58.8224
Low
56.3297
52 wk Range
47.0401-103.8099
Market Cap
3 318 M
Shares Outstanding
55 329 K
Revenue
249 M
EPS
-0.45
Beta
1.094
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Procept Biorobotics Corp data using free add-ons & libraries
Get Procept Biorobotics Corp Fundamental Data
Procept Biorobotics Corp Fundamental data includes:
- Net Revenue: 249 M
- EBITDA: -90 878 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-29
- EPS/Forecast: -0.4913
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Procept Biorobotics Corp News
New
Oppenheimer initiates coverage on Procept BioRobotics stock with Perform rating
Investing.com - Oppenheimer initiated coverage on Procept BioRobotics Corp (NASDAQ:PRCT) with a Perform rating on Monday, citing a balanced risk-reward assessment at current levels. The company, curre...
PRCT shares drop 41% after InvestingPro's overvaluation warning proves accurate
When InvestingPro’s Fair Value models flagged (NASDAQ:PRCT) as significantly overvalued in November 2024, the stock was trading at $93.60. Seven months later, this bearish call has proven remarkably...
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
SAN JOSE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformativ...
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
PROCEPT BioRobotics SAN JOSE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by devel...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
